Viewing Study NCT01857895


Ignite Creation Date: 2025-12-24 @ 1:52 PM
Ignite Modification Date: 2026-01-22 @ 3:32 AM
Study NCT ID: NCT01857895
Status: COMPLETED
Last Update Posted: 2017-10-19
First Post: 2013-05-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module